Site of origin |
Gender |
Age |
Histology |
Initial stage |
Metastatic site |
Treatment |
Evolution |
Maxillary sinus |
M |
23 |
Rhabdomyosarcoma
Grade III |
Metastatic |
Lung |
Chemotherapy: ifosfamide, doxorubicin |
Disease progression, 2nd line by docetaxel |
Infra-temporal Fossa |
M |
17 |
Rhabdomyosarcoma
Grade II |
Metastatic |
Lung, bone |
- |
Pulmonary embolism leading to death |
Nasal cavity |
M |
20 |
Rhabdomyosarcoma
Grade III |
Metastatic |
Lung |
Chemotherapy: ifosfamide, doxorubicin |
Disease progression and death |
Neck |
F |
34 |
Léiomyosarcoma
Grade II |
Metastatic |
Lung, lymph nodes |
Chemotherapy: doxorubicin |
Disease progression |
Conjonctiva |
M |
29 |
Léiomyosarcoma
Grade I |
Localized |
- |
Resection R0 + Chemotherapy: ifosfamide, doxorubicin |
No recurrence after 4 years |
Mandible |
M |
30 |
Osteosarcoma
Grade III |
Locally advanced |
- |
Resection R2 + Chemotherapy: cisplatine, doxorubicin |
Disease progression , 2nd line by cisplatine+etoposide |
Larynx |
F |
44 |
Chondrosarcoma
Grade II |
Localized |
- |
Surgery: total laryngectomy R1 + radiation therapy |
Local and distance recurrence after 4 months + Pulmonary embolism leading to death |
Oropharynx |
F |
28 |
Fibrosarcoma
Grade III |
Metastatic |
Lung, bone |
Chemotherapy: ifosfamide, doxorubicin |
Disease progression, base supportive care |
Neck |
F |
38 |
Fibromyosarcoma
Grade I |
Metastatic |
Lung, lymph nodes |
Chemotherapy: doxorubicin |
Progression , 2nd line by ifosfamide |
Thyroid |
F |
65 |
carcinosarcoma |
Localized |
- |
Total throidectomyR0 |
No recurrence after 2 years |